Joy MS, Karagiannis PC, Peyerl FW. Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment. J Manag Care Pharm. 2007;13(5):397-411. doi:10.18553/jmcp.2007.13.5.397. View Article
Boston Strategic Partners, Inc.
Healthcare strategy, economics, communication, regulatory affairs, financial advisory, and visual analytics
Joy MS, Karagiannis PC, Peyerl FW. Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment. J Manag Care Pharm. 2007;13(5):397-411. doi:10.18553/jmcp.2007.13.5.397. View Article